CST

Cellestis (CST)

Stock Code

CST

Stock Exchange

ax

Cellestis Limited (CST) is a company engaged in the development, manufacturing as well as marketing of different medical diagnostic products and scientific research. It is also engaged in the commercialisation and development of the technology products of QuantiFERON for scientific research and medical diagnosis in the world. It has main and principal operations in the US, Europe and Australia. CST was listed on the Australian Stock Exchange on the 24th of April, 2001. Its average annual revenue reaches approximately AUD$10 million.

Cellestis Dividends

1 September, 2010 - 13:39

Study the dividend history for CELLESTIS LIMITED. Dividends are a portion of company profits paid out to shareholders. You are eligible to receive CST dividends if you own the CELLESTIS LIMITED shares on the ex-dividend date. Traders and investors must purchase the stock before the exdividend date to be entitled to the dividend. The previous owner of the shares will receive the CST dividend if you buy the stocks on or after the ex dividend date.

Syndicate content